1,3-dimethylol-5,5-dimethylhydantoin has been researched along with Dermatitis, Atopic in 1 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belsito, DV; Malajian, D; Shaughnessy, CN | 1 |
1 other study(ies) available for 1,3-dimethylol-5,5-dimethylhydantoin and Dermatitis, Atopic
| Article | Year |
|---|---|
Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives.
Topics: Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Hydantoins; Incidence; Male; Methenamine; Patch Tests; Preservatives, Pharmaceutical; Propylene Glycols; Sex Factors; Urea | 2014 |